Surgical vs Non-Surgical Procedures – The “Great Debate” of 2022

Balancing Risks and Rewards: Examining the Divide Between Surgical and Non-Surgical Interventions in Modern Healthcare

Darius
Aug 15, 20234 min read
Surgical vs Non-Surgical Procedures – The “Great Debate” of 2022

FIGUR8’s clinical experts discuss the findings of a recent BMJ study, not the size and scope of the universe as Shapley and Curtis did in 1920.

A recent New York Times article summarized a study published in the British Medical Journal that examined the effectiveness of common orthopedic surgical procedures. Their findings outlined that for many common procedures, non-surgical options like diet, exercise and physical therapy are just as effective. The FIGUR8 communications team sat down with our Chief Medical Officer, Dr. Michael Oberlander who is an orthopedic surgeon, and our Business Development Manager, Josh Williams, a physical therapist himself, to discuss the implications of these findings.

FIGUR8: Thank you both for taking the time to speak with us today. Someone reading the article in the New York Times, at first glance, may think that surgery should never be an option, though this is probably not true. Dr. Oberlander, I’ll start with you, when is surgery the right choice for someone?

Dr. Oberlander: Generally speaking, surgery is indicated for MSK conditions when conservative treatment has failed and a valid procedure will result in a successful outcome in the majority of patients. In a small percentage of cases such as specific fractures, major soft tissue injuries, and certain tumors, surgery is primarily indicated. For the other 90% of cases, conservative care is the primary treatment of choice.

FIGUR8: That’s very helpful to know. So, for 90% of cases conservative treatment should be the first choice. The article mentions exercise, diet and physical therapy as effective options for many bone and joint issues. Are these the most common options? What other alternatives are available to people if surgery is not appropriate?

Josh Williams: Yes, these are very common management strategies that a primary care provider might prescribe to address a musculoskeletal (MSK) issue. I would add education as an additional tool to help people manage their concerns. Sometimes when we are in pain, it is accompanied with feelings of anxiety and uncertainty. Working with a health professional to understand the underlying condition and the steps that you can take to reduce pain and improve function can be a very empowering and effective approach. There are also other non-surgical options available.

Dr. Oberlander: Yes, for many MSK conditions, both acute and chronic, physical therapy, home exercise +/- a period of relative rest are often the mainstays of conservative treatment. Additionally, anti-inflammatory medication and other over-the-counter medications like Tylenol may be helpful to control the pain. Steroid injections, hyaluronic acid or biologics such as PRP (Platelet Rich Plasma) and lipogems may also be helpful.

Diet is clearly beneficial for certain conditions that involve the weight bearing joints of the lower extremity, like the hips and knees as well as the spine, and that is because these joints experience exponential stress with certain activities. Patients with a high body mass index (BMI) can experience a significant reduction in their pain levels and an improvement in function in these locations with simple weight loss. For example, the knee experiences 3-7x the weight of the body during activities like stair climbing, squatting, kneeling or even walking. That means a loss of 10 lbs is like losing 30-70 lbs. on your knees with those activities. Bracing of a joint can also be beneficial in certain situations to support the joint and allow for healing during recovery.

It’s best to speak to your medical provider about these and other options if you are experiencing pain and a loss of function related to a MSK injury or disorder.

FIGUR8: So with all of these non-surgical options available and with the evidence for surgery lacking, what are the factors that lead to the high volumes of procedures that appear to offer little value when compared to non-surgical treatment?

Dr. Oberlander: First off, there should be clear evidence that surgery is beneficial in a significant percentage of patients prior to recommending this treatment option to a patient. The main issue in my opinion is that a lot of patients, as well as some surgeons, prefer a quick fix if one is available.

This should be considered only after a detailed discussion of the risks, alternatives and possible complications of both conservative and operative treatment. Unfortunately, there is often insufficient time for this educational discussion. The end result may be that the patient is unable to fully participate in the shared decision making process.

The US health system additionally favors reimbursement for surgical procedures over medical management, which at times may also play into the decision making process.

Josh Williams: Those are both good points Dr. Oberlander, and I agree. Often, reimbursement dictates clinical care and a recent example of this was the explosion of virtual care as a result of COVID-19. For years, there was evidence of the benefits of virtual care but it wasn’t until the introduction of a billing framework by Medicare and other regulatory bodies that this became a consistent part of care delivery.

And on the topic of quick fixes, diet, exercise and physical therapy can be burdensome and the results are not always quick. Many MSK injuries take weeks or months to fully heal and require a concentrated effort on the part of the injured individual to attend their PT appointments, do their home exercises consistently and often work through pain.

FIGUR8: The BMJ study was an analysis of only randomized, controlled trials (RCT) but there are other ways to assess the effectiveness of medical treatments like case studies, observational analysis and expert opinions. Are randomized, controlled trials the only way that we should be evaluating the effectiveness of orthopedic surgical procedures?

Dr. Oberlander: Randomized controlled trials are one of the best ways to measure the value of medical and surgical treatment but by no means are they without inherent bias as well or the only means of measuring such. In many situations, a RCT with a blinded control group is unethical or impractical for humanitarian or financial reasons. They are also logistically difficult to set up and complete, requiring significant monetary support and human resources.

Josh Williams: RCTs are often held up as the gold standard in research and my training as a physical therapist happened at a time when evidence-based medicine was the predominant theoretical construct. Since then I think we have learned that there are other ways to evaluate medical interventions. Recently with COVID, we have seen real-world evidence inform policy decisions around public health measures or vaccination schedules. One of the drawbacks with RCTs is the ability to recreate the conditions in the real world. Oftentimes people don’t fit the characteristics of the sample size, or can’t fully commit to the intensity of a treatment regime because of other things going on in their lives like work or family commitments. These things are not often considered in the design of a large-scale trial.

FIGUR8: So moving forward what measurements or methodologies do you think we should be using to determine if a surgical or non-surgical treatment was beneficial?

Dr. Oberlander: Utilizing established validated peer reviewed patient reported outcome measures as well as functional outcome measures are the most effective ways to quantitatively and qualitatively assess the beneficial effects of treatment.

Josh Williams: I think that there is also tremendous value in highly accurate and reproducible data solutions like the FIGUR8 platform. This type of applied science will become the standard of care for measurement and data for musculoskeletal conditions. Because the platform is accessible at the point-of-care and deployed in a real-world environment, many of the shortcomings of RCTs are mitigated. The extremely rich data sets, when compiled at scale, will yield tremendous insights and uncover the effectiveness of various treatment approaches to inform a more precise approach to individualized patient care.

Disclaimer: The opinions contained within this interview are that of the participants and should not be considered medical advice. If you are managing a musculoskeletal condition, please speak to your physician or primary care provider about the options available to you.

FIGUR8

Related posts

  • [object Object]

    Movement pattern recognition – a quantum leap from half a dozen points of interest to over a million data points

    https://www.youtube.com/watch?v=Dg20pIkkzh8

    Watch the video above and tell me what you see. It’s not very long and you might not know what to look for, or what’s even important. But ask an expert clinician and they might tell you that they see the following:

    Start of Movement

    • Thighs fully supported on chair, pelvis in posterior tilt, thoracic kyphosis.
    • Knees flexed to bring feet under chair

    During Movement

    • Shoulders and trunk move forward
    • Excessive trunk flexion to move center of mass over new base of support (feet)
    • Pauses during lift-off prior to hip and knee extension
    • Tibias translate anterior over feet

      End of Movement
    • Stable base of support and no balance reactions observed in standing position
    • Hips and knees flexed and anterior to ankles/feet

      Now what do you do with those observations? What is important, what can be changed, and how can progress even be monitored? Like the quote above from Clay Christensen, to answer these questions we rely on highly-trained and expensive professionals, that through education and experience have developed insights as to what might be important, what works and doesn’t work and how to describe change over time.
    • The problem?
    • A professional’s database is limited by their experience. If there has not been the same intensity of training and experimentation to develop the pattern recognition skills required to deliver effective treatment, then the results will be sub-optimal. And this is exactly what we see – variability in care and outcomes across professional groups, geographies, and provider networks.
    • Those 8 observations above were provided by an expert clinician who was able to view the 16-second video clip a number of times to come up with the data that would inform the approach to treatment. Would a novice clinician be able to identify the same points of interest and deliver similar observations, either in scale or scope. Not likely; perhaps they would be able to note two or three points of interest and an observation at one point in time about each.
    • But movement is not a discrete activity, it is the interplay of a complex system of neurological inputs, joint motion and muscle outputs. And yet, providers continue to rely on static measures of movement, like range of motion and manual muscle tests, that are not evaluated during dynamic movement or over time. MSK health requires a more continuous set of biomarkers to understand deficiencies.
    • Imagine a tool that would allow any provider, from novice to expert, to capture time series data during functional activities from multiple segments and in multiple dimensions. That is the value of FIGUR8. Not only does a provider get access to the legacy metrics that they currently use as part of their physical exam, like range of motion, in addition they can view so much more data – thanks to the technology embedded within FIGUR8’s hardware, which can deliver over 4000 discrete data points per second.
    • That amount of data can seem overwhelming to a group that has been used to capturing only 3-8 observations during a movement analysis but it is the simplicity of the FIGUR8 platform that takes that high level of volume and converts it into easy to understand and clinically meaningful metrics. For example, a sit-to-stand evaluation delivers metrics on muscle output, including timing, amplitude and duration of muscle contraction, like in the graphs below.
      https://images.prismic.io/figur8tech/ZiubQvPdc1huK3fS_quantum-leap-1.png?auto=format,compress
      This raw output can then be summarized to evaluate symmetry between the left and right lower extremities, or between the agonist and antagonist muscle groups at different phases of the movement, like in the graphs below.
      https://images.prismic.io/figur8tech/ZiubOfPdc1huK3fR_quantum-leap-2.png?auto=format,compress
      It is a quantum leap from the generalized observations of an expert clinician, and just like the simplicity of our visualizations, the FIGUR8 software and mobile app is purpose fit to be deployed by providers in any setting. Now the solution can be delivered in more places at a lower cost, making expertise more accessible to a larger segment of the population and begin to meet the unfulfilled promise outlined in Christensen’s quote.
    Apr 14, 20224 min read
  • [object Object]

    Program to help those with knee injuries launched by Figur8

    Turn on any sporting event and you are likely to observe or hear about athletes that are playing with or have sustained knee injuries that prevents them from performing at the level they would like. But knee pain and injuries extend beyond the playing field into our personal and professional lives.

    Outside of spinal-related issues like low back pain, knee pain is the number one reason that people visit a provider that works in an outpatient or clinic setting,with over 12.4 million visits per year on average.1 And it’s not just the amount of visits that is concerning, it’s also the costs associated with providing care either immediately after the injury or as a result of lingering issues after initial treatment. For example, the average lifetime costs for an individual diagnosed with knee osteoarthritis, usually caused by “wear and tear” on the knee joint over time, are over $140,000.2

    In our professional lives, knee injuries are the second (9%) most commonly injured body part in the work environment that results in one or more days away from work (DAFW). Knee sprains, strains, and tears are the leading diagnoses for knee injuries resulting in DAFW among private industry (56%) and state and local government (51% each). And similar to above, it’s not just the frequency of knee injuries that is a problem; the average claim for a work-related knee injury is $34,003 and includes $18,052 in medical costs and $15,951 in indemnity costs.3

    It’s for these reasons that FIGUR8 has launched the first of its kind, acute knee MSK health evaluation. Consisting of 6 activities, this comprehensive evaluation provides patients, providers and payers with transparency into the severity and recovery progress of individuals with knee pain.

    FIGUR8 Acute Knee MSK Health Evaluation – Activities


    In less than 15 minutes, the FIGUR8 solution will deliver data on key musculoskeletal biomarkers, including range of motion, movement quality, strength and functional mobility.

    “FIGUR8 can clearly show the ups and downs of a patient’s rehab and detect changes in performance that can be correlated with changes in lower extremity strength and pain. This data provides information for an individualized plan of care.”
    – Dan McGovern, Physical Therapist

    FIGUR8 Acute Knee MSK Health Evaluation – Metrics


    At FIGUR8 we believe that data should drive decision-making and we are building a solution that puts data in the hands of all parties so that they can make, and have confidence in, the decisions and deliver precision musculoskeletal (MSK) health management to injured workers.

    Want to learn more about our acute knee MSK health evaluation? Connect with our team at info@figur8tech.com and book a one-to-one demo.

    References

    1 Song, A., Kim, P., Ayers, G., Jain, N. (2021) Characteristics of Non-Spine Musculoskeletal Ambulatory Care Visits in the United States; 2009-2016. Physical Medicine and Rehabilitation. 13(5):443-452.

    2 Losina, E., Palitel, D., Weinstein, AM., Yelin, E., Hunter, DJ., Chen, SP., Klara, K., Suter, LG., Solomon, DH., Burbine, SA., Walensky, RP., Katz, JN. (2014) Lifetime Medical Costs of Knee Osteoarthritis Management in the United States. Impact of Extending Indications for Total Knee Arthroplasty. Arthritis Care and Research. 67(2).

    3 Workers’ Compensation Costs. NSC Injury Facts. Accessed from: https://injuryfacts.nsc.org/work/costs/workers-compensation-costs/

    Jan 11, 20224 min read